InvestorsHub Logo

jq1234

06/17/13 11:34 PM

#162663 RE: jaybe #162662

Per Lancet, yes, it used ORR. It is fine to report either or both best response and ORR depends on data availability as long as they are clearly stated in presentations. All three of them stated clearly what they presented, no intention to mislead, it is up to individual how to interpret data.

biomaven0

06/17/13 11:49 PM

#162664 RE: jaybe #162662

Ariad's conservative data presentations over Novartis-types



I don't see either Ariad or Novartis poster presentations as anything other than neutral.

Harvey's presentations tend to be a lot more promotional than Novartis' presentations of course.

Peter